Nancy Thornberry

Insider Reports History

Entity
Individual
Location
Schrodinger, Inc., 120 West 45 Th Street, 17 Th Floor, New York, NY
Signature
/s/ Donald Shum, as attorney-in-fact for Nancy Thornberry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Thornberry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA Director Common Stock 1.64K $660K $402.95 May 1, 2024 Direct
Denali Therapeutics Inc. Director Common Stock 18.7K $381K $20.39 May 31, 2024 Direct
VERTEX PHARMACEUTICALS INC / MA Director Stock Option (Right to Buy) 1.57K $200K $127.54 May 1, 2024 Direct
Schrodinger, Inc. Director Common Stock 11.3K $48.8K $4.34 Jun 18, 2024 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 17.9K May 31, 2024 Direct
Schrodinger, Inc. Director Stock Option (right to buy) 8.55K Jun 18, 2024 Direct

Insider Reports Filed by Nancy Thornberry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SDGR Schrodinger, Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
DNLI Denali Therapeutics Inc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
VRTX VERTEX PHARMACEUTICALS INC / MA May 1, 2024 2 $0 4 May 3, 2024 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Dec 5, 2023 1 $0 4 Dec 6, 2023 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Dec 5, 2023 0 $0 3 Dec 6, 2023 Director
SDGR Schrodinger, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
DNLI Denali Therapeutics Inc. Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
SDGR Schrodinger, Inc. May 22, 2023 3 -$349K 4 May 23, 2023 Director
SDGR Schrodinger, Inc. Aug 11, 2022 3 -$116K 4 Aug 12, 2022 Director
SDGR Schrodinger, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
DNLI Denali Therapeutics Inc. Jun 2, 2022 2 $0 4 Jun 6, 2022 Director
DNLI Denali Therapeutics Inc. Jan 8, 2022 1 $0 4 Jan 11, 2022 Director
SDGR Schrodinger, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director